Answer
Givlaari (givosiran sodium) has no or limited pregnancy data in humans, animal studies showed reproductive toxicity with maternal toxicity, and use during pregnancy may be considered after weighing the expected health benefit for the woman against potential fetal risks.
Sources for this answer
- GivlaariAlnylam UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked